PLASMA AND CELLULAR ADRIAMYCIN CONCENTRATIONS IN PATIENTS WITH MYELOMA TREATED WITH 96-HOUR CONTINUOUS INFUSION

被引:46
作者
SPETH, PAJ [1 ]
LINSSEN, PCM [1 ]
HOLDRINET, RSG [1 ]
HAANEN, C [1 ]
机构
[1] ST RADBOUD UNIV HOSP,DEPT HEMATOL,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1038/clpt.1987.92
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:661 / 665
页数:5
相关论文
共 15 条
[1]  
ALEXANIAN R, 1986, P AM SOC CLIN ONCOL, V5, P653
[2]   EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS [J].
BARLOGIE, B ;
SMITH, L ;
ALEXANIAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) :1353-1356
[3]  
CATOVSKY D, 1983, EORTC CANCER CHEMOTH, V5, P217
[4]  
DREWINKO B, 1981, CANCER RES, V41, P2328
[5]  
DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[6]  
2-U
[7]   DEPENDENCE OF THE CYTOSTATIC EFFECT OF ADRIAMYCIN ON DRUG CONCENTRATION AND EXPOSURE TIME INVITRO [J].
EICHHOLTZWIRTH, H .
BRITISH JOURNAL OF CANCER, 1980, 41 (06) :886-891
[8]  
HOLDRINET RSG, 1980, EXP HEMATOL, V8, P103
[9]  
JACKSON D, 1985, P AM ASS CANCER RES, V5, P839
[10]  
KYLE RA, 1982, CANCER TREAT REP, V66, P451